Search Result

Isoforms Recommended:	mGluR1

Results for "

MGLUR1

" in MedChemExpress (MCE) Product Catalog:

By Targets:	CaMK (1) CaSR (1) Endogenous Metabolite (8) ERK (2) GABA Receptor (2) iGluR (1) Isotope-Labeled Compounds (1) mGluR (43) Phosphatase (1) Reference Standards (3) Small Interfering RNA (siRNA) (2) Tau Protein (1)
By Research Areas:	Cancer (3) Cardiovascular Disease (1) Neurological Disease (42)
Oligonucleotides:	Mouse Pre-designed siRNA Sets (1) Human Pre-designed siRNA Sets (1) siRNAs (2)

Inhibitors & Agonists

Natural
Products

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-100382

FPTQ	mGluR	Others
FPTQ is potent *mGluR₁* antagonist with IC₅₀ values of 6 nM and 1.4 nM for human and mouse mGluR1 respectively ^[1]. FPTQ has anti-oxidant and anti-inflammatory effects in vitro and in vivo .

HY-107507

Ro 01-6128 1 Publications Verification	mGluR	Neurological Disease
Ro 01-6128 is a positive allosteric modulator of *mGluR1* ^[1].

HY-14612

CPPHA	mGluR	Neurological Disease
CPPHA is potent and selective positive allosteric modulator (PAM) of the *mGluR5* and *mGluR1* (metabotropic glutamate receptor). CPPHA can potentiate responses of mGluR5 and mGluR1 to activation of these receptors. CPPHA is developed for the research of central nervous system disorders ^[1] .

HY-RS05819

GRM1 Human Pre-designed siRNA Set A MGLU1; SCA44; GPRC1A; MGLUR1; SCAR13; PPP1R85	Small Interfering RNA (siRNA)	Others
GRM1 Human Pre-designed siRNA Set A contains three designed siRNAs for GRM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRM1 Human Pre-designed siRNA Set A GRM1 Human Pre-designed siRNA Set A

HY-RS05820

Grm1 Mouse Pre-designed siRNA Set A rcw; wobl; Gprc1a; MGLUR1; nmf373; Gm10828; 4930455H15Rik	Small Interfering RNA (siRNA)	Others
Grm1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Grm1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Grm1 Mouse Pre-designed siRNA Set A Grm1 Mouse Pre-designed siRNA Set A

HY-W714513

VU0469650 hydrochloride	mGluR	Neurological Disease
VU0469650 hydrochloride is a brain-penetrant negative allosteric modulator of metabotropic glutamate receptor 1 (mGluR1). VU0469650 hydrochloride inhibits glutamate-induced calcium flux in cells expressing human mGluR1 (IC₅₀= 99 nM). VU0469650 hydrochloride is promising for research of central nervous system diseases such as anxiety, addiction, and epilepsy ^[1].

HY-100841A

(S)-3-Hydroxyphenylglycine (S)-3HPG	mGluR	Neurological Disease
(S)-3-Hydroxyphenylglycine ((S)-3HPG) is a potent *mGluR₁* agonist without effect at mGlu₂ or mGlu₄ ^[1].

HY-117132

YM-202074	mGluR	Neurological Disease
YM-202074 is a selective, allosteric metabotropic glutamate receptor type 1 (mGluR1) antagonist with high affinity. YM-202074 binds to the allosteric site of rat *mGluR1* with a K_i of 4.8 nM. YM-202074 fumarate also inhibits *mGluR1*-mediated inositol phosphate production in rat cerebellar granule cells with an IC₅₀ of 8.6 nM. YM-202074 has potent neuroprotective effects in transient MCA (tMCA) occlusion rat models ^[1].

HY-103556

YM-202074 fumarate	mGluR	Neurological Disease
YM-202074 fumarate is a selective, allosteric metabotropic glutamate receptor type 1 (mGluR1) antagonist with high affinity. YM-202074 fumarate binds to the allosteric site of rat *mGluR1* with a K_i of 4.8 nM. YM-202074 fumarate also inhibits *mGluR1*-mediated inositol phosphate production in rat cerebellar granule cells with an IC₅₀ of 8.6 nM. YM-202074 fumarate has potent neuroprotective effects in transient MCA (tMCA) occlusion rat models ^[1].

HY-170499

VU6024578 BI02982816	mGluR	Neurological Disease
VU6024578 (BI02982816) is a selective, orally active positive allosteric modulator (PAM) for metabotropic glutamate receptor (mGluR1), that activates human mGluR1 and rat mGluR1 with EC₅₀ of 54 nM and 46 nM. VU6024578 exhibits antipsychotic activity in rats amphetamine-induced hyperactivity models and MK-801 (HY-15084B)-induced novel object recognition (NOR) models. VU6024578 is blood brain barrier penetrable ^[1].

HY-116723

CFMMC	mGluR	Neurological Disease
CFMMC is a selective allosteric metabotropic glutamate receptor 1 (mGluR1) antagonist. CFMMC inhibits L-glutamate-induced intracellular Ca ²⁺ mobilization ([Ca ²⁺]i) in Chinese hamster ovary cells expressing recombinant human mGluR1a with an IC₅₀ value of 50 nM. CFMMC is promising for research of various central nervous system disorders, such as schizophrenia, epilepsy, anxiety, pain, cognitive dysfunction and drug abuse ^[1].

HY-162860

FO-4-15	mGluR CaMK Tau Protein	Neurological Disease
FO-4-15 is an mGluR1/CaMKIIα activator. FO-4-15 has a protective effect against H₂O₂ in human neuroblastoma (SH-SY5Y) cells. FO-4-15 can improve cognitive impairment in Alzheimer’s disease mice by activating the mGluR1/CaMKIIα pathway, and can reduce Aβ accumulation, hyperphosphorylated Tau, and synaptic damage ^[1].

HY-100403

Ro 67-7476 Maximum Cited Publications 12 Publications Verification	mGluR	Cancer
Ro 67-7476 is a potent positive allosteric modulator of *mGluR₁* and potentiates glutamate-induced calcium release in HEK293 cells expressing rat mGluR1a with an EC₅₀ of 60.1 nM ^[1] . Ro 67-7476 is a potent P-ERK1/2 agonist and activates ERK1/2 phosphorylation in the absence of exogenously added glutamate (EC₅₀=163.3 nM) .

HY-119097

LY456066	mGluR	Neurological Disease
LY456066 is a selective non-competitive metabotropic glutamate receptors (mGluR1) antagonist with an IC₅₀ value of 52.0 nM. LY456066 is effective in rodent models of anxiolysis and nociception. LY456066 reduces hyperalgesia and the amount of licking and flinching following formalin injection, which is promising for research of analgesics for chronic pain ^[1] .

HY-100405

FTIDC	mGluR	Neurological Disease
FTIDC is an orally active, noncompetitive, selective allosteric metabotropic glutamate receptor (mGluR) 1 antagonist with an IC₅₀ of 5.8 nM for human mGluR1a. FTIDC has no species differences in its antagonistic activity on recombinant human, mouse, and rat mGluR1 ^[1].

HY-11095

NPS 2390	mGluR CaSR	Cardiovascular Disease Neurological Disease
NPS 2390 is a noncompetitive antagonist of mGluR1 and mGluR5 ^[1]. NPS 2390 is also a potent CaSR (calcium-sensing receptor) inhibitor .

HY-103568

YM-298198 hydrochloride	mGluR	Neurological Disease
YM-298198 hydrochloride is a high-affinity, selective, orally active, and non-competitive antagonist of metabotropic glutamate receptor type 1 (mGluR1). YM-298198 hydrochloride can be used for the research of neurological disorders ^[1].

HY-100786

DL-AP3	Endogenous Metabolite mGluR Phosphatase	Neurological Disease Cancer
DL-AP3 is a competitive *mGluR1* and *mGluR5* antagonist. DL-AP3 is also an inhibitor of phosphoserine phosphatase. DL-AP3 has neuroprotective effect ^[1] .

HY-103567

Desmethyl-YM-298198 hydrochloride	mGluR	Neurological Disease
Desmethyl-YM-298198 hydrochloride is a high-affinity, selective, and noncompetitive *mGluR1* antagonist (IC₅₀: 16 nM). Desmethyl-YM-298198 hydrochloride has analgesic effect in Streptozotocin (HY-13753)-induced hyperalgesic mice ^[1].

HY-103567A

Desmethyl-YM-298198	mGluR	Neurological Disease
Desmethyl-YM-298198 is a high-affinity, selective, and noncompetitive *mGluR1* antagonist (IC₅₀: 16 nM). Desmethyl-YM-298198 has analgesic effect in Streptozotocin (HY-13753)-induced hyperalgesic mice ^[1].

HY-100841

(Rac)-3-Hydroxyphenylglycine 3HPG	mGluR	Neurological Disease
(Rac)-3-Hydroxyphenylglycine (3HPG) is a racemic mixture of (S)-3-hydroxyphenylglycine and (R)-3-hydroxyphenylglycine. (S)-3-Hydroxyphenylglycine is a potent and selective mGluR1 agonist ^[1] .

HY-107457

AZD-8529 1 Publications Verification	mGluR	Neurological Disease
AZD-8529 is a potent, highly selective and orally bioavailable positive allosteric modulator of *mGluR2, with an EC₅₀* of 285 nM, and shows no positive allosteric modulator responses at 20-25 M on the mGluR1, 3, 4, 5, 6, 7, and 8 subtypes.

HY-107457A

AZD-8529 mesylate 1 Publications Verification	mGluR	Neurological Disease
AZD-8529 mesylate is a potent, highly selective and orally bioavailable positive allosteric modulator of *mGluR2, with an EC₅₀* of 285 nM, and shows no positive allosteric modulator responses at 20-25 M on the mGluR1, 3, 4, 5, 6, 7, and 8 subtypes ^[1].

HY-15129

O-Phospho-L-serine 2 Publications Verification L-Serine O-phosphate; L-SOP	mGluR Endogenous Metabolite	Neurological Disease
O-Phospho-L-serine is the immediate precursor to L-cystein in the serine synthesis pathway, and an agonist at the *group III mGluR* receptors** (mGluR4, mGluR6, mGluR7, and mGluR8); O-Phospho-L-serine also acts as a weak antagonist for *mGluR1* and a potent antagonist for *mGluR2* ^[1].

HY-100804

L-Cysteinesulfinic acid	mGluR Endogenous Metabolite	Neurological Disease
L-Cysteinesulfinic acid is a potent agonist at several rat metabotropic glutamate receptors (mGluRs) with pEC₅₀s of 3.92, 4.6, 3.9, 2.7, 4.0, and 3.94 for mGluR1, mGluR5, mGluR2, mGluR4, mGluR6, and mGluR8, respectively ^[1].

HY-W017230

L-Cysteinesulfinic acid monohydrate	mGluR Endogenous Metabolite	Neurological Disease
L-Cysteinesulfinic acid monohydrate is a potent agonist at several rat metabotropic glutamate receptors (mGluRs) with pEC₅₀s of 3.92, 4.6, 3.9, 2.7, 4.0, and 3.94 for mGluR1, mGluR5, mGluR2, mGluR4, mGluR6, and mGluR8, respectively ^[1].

HY-129636

CLH304a (E)-GABAB receptor antagonist 1	GABA Receptor ERK	Neurological Disease
CLH304a (compound 14) is a specific and noncompetitive GABA_B receptor negative allosteric modulator (NAM). CLH304a decreases GABA-induced IP3 production with an IC₅₀ of 37.9 μM. CLH304a has no effect on other GPCR Class C members such as mGluR1, mGluR2, and mGluR5. CLH304a acts on the heptahelical domain of GB2 subunits and non-competitively inhibits the effect of agonists with inverse agonist properties. CLH304a inhibits Baclofen (HY-B0007)-induced ERK1/2 phosphorylation in HEK293 cells overexpressing GABA_B receptor ^[1] .

HY-100804R

L-Cysteinesulfinic acid (Standard)	Reference Standards mGluR Endogenous Metabolite	Neurological Disease
L-Cysteinesulfinic acid (Standard) is the analytical standard of L-Cysteinesulfinic acid. This product is intended for research and analytical applications. L-Cysteinesulfinic acid is a potent agonist at several rat metabotropic glutamate receptors (mGluRs) with pEC50s of 3.92, 4.6, 3.9, 2.7, 4.0, and 3.94 for mGluR1, mGluR5, mGluR2, mGluR4, mGluR6, and mGluR8, respectively ^[1].

HY-100840A

(RS)-4C3HPG 4-Carboxy-3-hydroxyphenylglycine	mGluR	Neurological Disease
(RS)-4C3HPG (4-Carboxy-3-hydroxyphenylglycine) is an effective competitive antagonist at the metabotropic glutamate receptor 1 (mGluR1) in the central nervous system, and it is also an agonist at *mGluR2/3*. (RS)-4C3HPG exhibits neuroprotective effects in an acute global ischemia rat model ^[1] .

HY-15129S

O-Phospho-L-serine-13C3,15N L-Serine O-phosphate-¹³C₃,¹⁵N; L-SOP-¹³C₃,¹⁵N	mGluR Endogenous Metabolite	Neurological Disease
O-Phospho-L-serine- ¹³C₃, ¹⁵N is the ¹³C- and ¹⁵N-labeled O-Phospho-L-serine. O-Phospho-L-serine is the immediate precursor to L-serine in the serine synthesis pathway, and an agonist at the group III mGluR receptors (mGluR4, mGluR6, mGluR7, and mGluR8); O-Phospho-L-serine also acts as a weak antagonist for mGluR1 and a potent antagonist for mGluR2 ^[1].

HY-W751156

O-Phospho-L-serine-13C3 L-Serine O-phosphate-¹³C₃; L-SOP-¹³C₃	Isotope-Labeled Compounds mGluR Endogenous Metabolite	Neurological Disease
O-Phospho-L-serine- ¹³C₃ (L-Serine O-phosphate- ¹³C₃) is the ¹³C-labeled O-Phospho-L-serine (HY-15129). O-Phospho-L-serine is the immediate precursor to L-cystein in the serine synthesis pathway, and an agonist at the group III mGluR receptors (mGluR4, mGluR6, mGluR7, and mGluR8); O-Phospho-L-serine also acts as a weak antagonist for mGluR1 and a potent antagonist for mGluR2 ^[1].

HY-15129R

O-Phospho-L-serine (Standard) L-Serine O-phosphate (Standard); L-SOP (Standard)	Reference Standards mGluR Endogenous Metabolite	Neurological Disease
O-Phospho-L-serine (Standard) (L-Serine O-phosphate (Standard)) is the analytical standard of O-Phospho-L-serine (HY-15129). This product is intended for research and analytical applications. O-Phospho-L-serine is the immediate precursor to L-cystein in the serine synthesis pathway, and an agonist at the group III mGluR receptors (mGluR4, mGluR6, mGluR7, and mGluR8). O-Phospho-L-serine also acts as a weak antagonist for mGluR1 and a potent antagonist for mGluR2.

HY-107506

Ro 67-4853	mGluR	Neurological Disease
Ro 67-4853 is a positive allosteric modulator (PAM) of *mGluR1* (pEC₅₀=7.16 for rmGlu1a receptor). Ro67-4853 exhibits activity at all group I mGlu receptors including hmGlu1, rmGlu1, and rmGlu5. Ro 67-4853 enhances the potency of L-Glu by interacting with the transmembrane domain (TMD) of the receptor. Ro 67-4853 potentiates sensory synaptic responses to repetitive vibrissa stimulation ^[1] .

HY-12598A

DHPG 4 Publications Verification (RS)-3,5-DHPG	mGluR	Neurological Disease
DHPG is the agonist for *mGluR 1/5* (EC₅₀ for mGluR 1 is 60 nM) that activates the phospholipase C (PLC) pathway, and leads ultimately to the activation of protein kinase C (PKC) ^[1].

HY-12598AR

DHPG (Standard)	mGluR	Neurological Disease
DHPG (Standard) is the analytical standard of DHPG. This product is intended for research and analytical applications. DHPG is the agonist for mGluR 1/5 (EC50 for mGluR 1 is 60 nM) that activates the phospholipase C (PLC) pathway, and leads ultimately to the activation of protein kinase C (PKC) ^[1].

HY-121848

VU0155094 ML397	mGluR	Neurological Disease
VU0155094 is a positive allosteric modulator with differential activity at the various group III mGluRs .

HY-101356

CPCCOEt	mGluR	Neurological Disease
CPCCOEt is a low affinity, selective, non-competitive and reversible antagonist of metabotropic glutamate receptor 1b (mGluR1b) ^[1] .

HY-100402

CFMTI	mGluR	Cancer
CFMTI inhibits L-glutamate-induced intracellular Ca ²⁺ mobilization in CHO cells expressing human and rat *mGluR1a, with IC₅₀*s of 2.6 and 2.3 nM, respectively ^[1].

HY-12597

Quisqualic acid L-Quisqualic acid	iGluR mGluR	Neurological Disease
Quisqualic acid (L-Quisqualic acid), a natural analog of glutamate, is a potent and pan two subsets (iGluR and *mGluR) of excitatory amino acid (EAA) agonist with an EC₅₀* of 45 nM and a K_i of 10 nM for mGluR1R. Quisqualic acid is isolated from the fruits of Quisqualis indica ^[1] .

HY-135464

(±)-LY367385	mGluR	Neurological Disease
(±)-LY367385 is the racemate of LY367385. LY367385 is a highly potent and selective *mGluR1a* antagonist. LY367385 has an IC₅₀ of 8.8 μM for inhibits of quisqualate-induced phosphoinositide (PI) hydrolysis，compared with > 100 μM for mGlu5a ^[1] .

HY-107515

LY367385 2 Publications Verification	mGluR	Neurological Disease
LY367385 is a highly selective and potent *mGluR1a* antagonist. LY367385 has an IC₅₀ of 8.8 μM for inhibiting of quisqualate-induced phosphoinositide (PI) hydrolysis, compared with >100 μM for mGlu5a. LY367385 has neuroprotective, anticonvulsant and antiepileptic effects ^[1] .

HY-107515A

LY367385 hydrochloride 2 Publications Verification	mGluR	Neurological Disease
LY367385 hydrochloride is a highly selective and potent *mGluR1a* antagonist. LY367385 hydrochloride has an IC₅₀ of 8.8 μM for inhibiting of quisqualate-induced phosphoinositide (PI) hydrolysis, compared with >100 μM for mGlu5a. LY367385 hydrochloride has neuroprotective, anticonvulsant and antiepileptic effects ^[1] .

HY-12598

(S)-3,5-DHPG	mGluR	Neurological Disease
(S)-3,5-DHPG is a weak, but selective group I metabotropic glutamate receptors (mGluRs) agonist with K_i values of 0.9 μM and 3.9 μM for mGluR1a and mGluR5a, respectively ^[1]. (S)-3,5-DHPG exhibits anxiolytic activity in rats subjected to hypoxia .

HY-100840

(S)-4C3HPG (S)-4-Carboxy-3-hydroxyphenylglycine	mGluR	Neurological Disease
(S)-4C3HPG ((S)-4-Carboxy-3-hydroxyphenylglycine) is an antagonist of metabotropic glutamate receptor 1a (mGluR 1a) and an agonist of *GluR2*. (S)-4C3HPG has the anticonvulsant activity and protects against audiogenic seizures in DBA/2 mice ^[1].

HY-129636A

(E/Z)-CLH304a GABAB receptor antagonist 1	GABA Receptor ERK	Neurological Disease
(E/Z)-CLH304a (GABAB receptor antagonist 1) is a mixture of (E)-CLH304a and (Z)-CLH304a. (E)-CLH304a (CLH304a; HY-129636) is a specific and noncompetitive GABA_B receptor negative allosteric modulator (NAM). CLH304a inhibits Baclofen (HY-B0007)-induced ERK1/2 phosphorylation in HEK293 cells overexpressing GABAB receptors ^[1] .

HY-100371R

(RS)-MCPG (Standard) alpha-MCPG (Standard)	Reference Standards mGluR	Neurological Disease
(RS)-MCPG (Standard) is the analytical standard of (RS)-MCPG. This product is intended for research and analytical applications. (RS)-MCPG (alpha-MCPG) is a competitive and selective group I/group II metabotropic glutamate receptor (mGluR) antagonist. (RS)-MCPG blocks theta-burst stimulation (TBS)-induced shifts in both juvenile and neonatal rat hippocampal neurons ^[1] .

HY-100371

(RS)-MCPG 1 Publications Verification alpha-MCPG	mGluR	Neurological Disease
(RS)-MCPG (alpha-MCPG) is a competitive and selective group I/group II metabotropic glutamate receptor (mGluR) antagonist. (RS)-MCPG blocks theta-burst stimulation (TBS)-induced shifts in both juvenile and neonatal rat hippocampal neurons ^[1] .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-100786

DL-AP3	Structural Classification Natural Products Human Gut Microbiota Metabolites Microorganisms Neurological Disease Classification of Application Fields Source classification Endogenous metabolite Disease Research Fields Cancer	Endogenous Metabolite mGluR Phosphatase
DL-AP3 is a competitive *mGluR1* and *mGluR5* antagonist. DL-AP3 is also an inhibitor of phosphoserine phosphatase. DL-AP3 has neuroprotective effect ^[1] .

HY-15129

O-Phospho-L-serine 2 Publications Verification L-Serine O-phosphate; L-SOP	Structural Classification Human Gut Microbiota Metabolites Immune System Disorder Microorganisms Ketones, Aldehydes, Acids Source classification Disease markers Endogenous metabolite	mGluR Endogenous Metabolite
O-Phospho-L-serine is the immediate precursor to L-cystein in the serine synthesis pathway, and an agonist at the *group III mGluR* receptors** (mGluR4, mGluR6, mGluR7, and mGluR8); O-Phospho-L-serine also acts as a weak antagonist for *mGluR1* and a potent antagonist for *mGluR2* ^[1].

HY-100804

L-Cysteinesulfinic acid	Structural Classification Ketones, Aldehydes, Acids Source classification Endogenous metabolite	mGluR Endogenous Metabolite
L-Cysteinesulfinic acid is a potent agonist at several rat metabotropic glutamate receptors (mGluRs) with pEC₅₀s of 3.92, 4.6, 3.9, 2.7, 4.0, and 3.94 for mGluR1, mGluR5, mGluR2, mGluR4, mGluR6, and mGluR8, respectively ^[1].

HY-W017230

L-Cysteinesulfinic acid monohydrate	Structural Classification Natural Products Neurological Disease Classification of Application Fields Source classification Endogenous metabolite Disease Research Fields	mGluR Endogenous Metabolite
L-Cysteinesulfinic acid monohydrate is a potent agonist at several rat metabotropic glutamate receptors (mGluRs) with pEC₅₀s of 3.92, 4.6, 3.9, 2.7, 4.0, and 3.94 for mGluR1, mGluR5, mGluR2, mGluR4, mGluR6, and mGluR8, respectively ^[1].

HY-12597

Quisqualic acid L-Quisqualic acid	Structural Classification Ketones, Aldehydes, Acids Combretaceae Source classification Plants Quisqualis indica Linn.	iGluR mGluR
Quisqualic acid (L-Quisqualic acid), a natural analog of glutamate, is a potent and pan two subsets (iGluR and *mGluR) of excitatory amino acid (EAA) agonist with an EC₅₀* of 45 nM and a K_i of 10 nM for mGluR1R. Quisqualic acid is isolated from the fruits of Quisqualis indica ^[1] .

HY-100804R

L-Cysteinesulfinic acid (Standard)	Structural Classification Ketones, Aldehydes, Acids Source classification Endogenous metabolite	Reference Standards mGluR Endogenous Metabolite
L-Cysteinesulfinic acid (Standard) is the analytical standard of L-Cysteinesulfinic acid. This product is intended for research and analytical applications. L-Cysteinesulfinic acid is a potent agonist at several rat metabotropic glutamate receptors (mGluRs) with pEC50s of 3.92, 4.6, 3.9, 2.7, 4.0, and 3.94 for mGluR1, mGluR5, mGluR2, mGluR4, mGluR6, and mGluR8, respectively ^[1].

Cat. No.	Compare	Product Name	Species	Source

HY-P703139

	GRM1 Protein, Human (sf9, Flag, His) GPRC1A; MGLUR1	Human	Sf9 insect cells
	GRM1 Protein, Human (sf9, Flag, His) is the recombinant human-derived GRM1, expressed by sf9 insect cells , with His, Flag labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name	Chemical Structure

HY-15129S

O-Phospho-L-serine-13C3,15N
O-Phospho-L-serine- ¹³C₃, ¹⁵N is the ¹³C- and ¹⁵N-labeled O-Phospho-L-serine. O-Phospho-L-serine is the immediate precursor to L-serine in the serine synthesis pathway, and an agonist at the group III mGluR receptors (mGluR4, mGluR6, mGluR7, and mGluR8); O-Phospho-L-serine also acts as a weak antagonist for mGluR1 and a potent antagonist for mGluR2 ^[1].

HY-W751156

O-Phospho-L-serine-13C3

O-Phospho-L-serine- ¹³C₃ (L-Serine O-phosphate- ¹³C₃) is the ¹³C-labeled O-Phospho-L-serine (HY-15129). O-Phospho-L-serine is the immediate precursor to L-cystein in the serine synthesis pathway, and an agonist at the group III mGluR receptors (mGluR4, mGluR6, mGluR7, and mGluR8); O-Phospho-L-serine also acts as a weak antagonist for mGluR1 and a potent antagonist for mGluR2 ^[1].

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P83450

	mGluR1 Antibody (YA3195) GRM1; GPRC1A; MGLUR1; Metabotropic glutamate receptor 1; MGLUR1	WB	Human, Mouse, Rat
	mGluR1 Antibody (YA3195) is a non-conjugated IgG antibody, targeting mGluR1, with a predicted molecular weight of 132 kDa (observed band size: 101 kDa). mGluR1 Antibody (YA3195) can be used for WB experiment in human, mouse, rat background.